Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity

被引:85
作者
Suo, ZM
Fang, CH
Crawford, F
Mullan, M
机构
[1] Roskamp Laboratories, Dept. Psychiat., 3515 E. Fletcher A., Tampa
关键词
beta-amyloid; Alzheimer's disease; cytotoxicity; endothelial cell; superoxide radical; intracellular calcium;
D O I
10.1016/S0006-8993(97)00383-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The 39-42 amino acid residue amyloid beta peptide (A beta), the major protein component in senile plaques and cerebrovascular amyloidosis in the brain in Alzheimer's disease (AD), has been shown to be neurotoxic in vitro. Accumulating data from several areas suggest that cerebrovascular dysfunction and damage may also play a significant role in the AD process. For instance, we have recently demonstrated enhanced vasoconstriction and resistance to relaxation in intact rat aorta treated with A beta [Thomas et al., beta-Amyloid-mediated vasoactivity and vascular endothelial damage, Nature, 380 (1996) 168-171]. Significant vessel damage occurred after thirty minutes of exposure, but could be prevented with superoxide dismutase. To further investigate the role of A beta toxicity on endothelial cells, we have applied A beta peptides to cultures of human aortic endothelial cells (HAEC). Our results show that both A beta(1-42) and A beta(25-35) are toxic to HAEC in a time- and dose-dependent manner, and that this toxicity can be partially prevented by the calcium channel blocker, verapamil, and the antioxidant, superoxide dismutase. The common form of A beta, A beta(1-40), which has been shown to be neurotoxic, is much less toxic to HAEC. A beta toxicity to HAEC occurs within 30 min of treatment with relatively lower doses than those usually observed in primary cultured neurons and vascular smooth muscle cells. It was recently reported that a variety of mutations in the beta-amyloid protein precursor gene and the Presenilin-1 and -2 genes linked to early-onset familial AD cause an increase in the plasma concentration of A beta(1-42) in mutation carriers [Scheuner et al., Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vitro by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nature Med., 2 (1996) 864-870]. Human aortic endothelial cells are more sensitive to A beta(1-42) than A beta(1-40), via a pathway involving an excess of superoxide free radicals and influx of extracellular calcium. Finally, we have evidence that both apoptotic and necrotic processes are activated by the A beta peptides in these endothelial cells. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:144 / 152
页数:9
相关论文
共 25 条
[1]   VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, J ;
COLE, GM ;
SCHUBERT, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :944-950
[2]   AMYLOID-BETA PEPTIDE INDUCES NECROSIS RATHER THAN APOPTOSIS [J].
BEHL, C ;
DAVIS, JB ;
KLIER, FG ;
SCHUBERT, D .
BRAIN RESEARCH, 1994, 645 (1-2) :253-264
[3]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[4]  
DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931
[5]   SOLUBLE BETA-AMYLOID INDUCTION OF ALZHEIMERS PHENOTYPE FOR HUMAN FIBROBLAST K+ CHANNELS [J].
ETCHEBERRIGARAY, R ;
ITO, E ;
KIM, CS ;
ALKON, DL .
SCIENCE, 1994, 264 (5156) :276-279
[6]   APOPTOSIS MEDIATED NEUROTOXICITY INDUCED BY CHRONIC APPLICATION OF BETA-AMYLOID FRAGMENT 25-35 [J].
FORLONI, G ;
CHIESA, R ;
SMIROLDO, S ;
VERGA, L ;
SALMONA, M ;
TAGLIAVINI, F ;
ANGERETTI, N .
NEUROREPORT, 1993, 4 (05) :523-526
[7]   APOLIPOPROTEIN-E EPSILON-4 AND CEREBRAL-HEMORRHAGE ASSOCIATED WITH AMYLOID ANGIOPATHY [J].
GREENBERG, SM ;
REBECK, GW ;
VONSATTEL, JPG ;
GOMEZISLA, T ;
HYMAN, BT .
ANNALS OF NEUROLOGY, 1995, 38 (02) :254-259
[8]  
GSCHWIND M, 1995, J NEUROCHEM, V65, P292
[9]   RE-EXAMINATION AND FURTHER DEVELOPMENT OF A PRECISE AND RAPID DYE METHOD FOR MEASURING CELL-GROWTH CELL KILL [J].
HANSEN, MB ;
NIELSEN, SE ;
BERG, K .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 119 (02) :203-210
[10]  
IVERSEN LL, 1995, BIOCHEM J, V311, P1